Modified alginate beads for Mucoadhesive drug delivery system: An updated review of patents

Recent Patents on Drug Delivery and Formulation

Volumn 6, Issue 3, 2012, Pages 259-277

  Swain, Suryakanta ^a   Behera, Aurobinda ^a   Beg, Sarwar ^a   Patra, Chinam N ^a   Dinda, Subash C ^b   Sruti, Jammula ^a   Rao, Muddana E B ^a  

^a Roland Institute of Pharmaceutical Science   (India)

^b BERHAMPUR UNIVERSITY   (India)

Author keywords

Biacore; Delivery approaches; Modified alginate beads; Pharmacokinetic advantages; Recent patents

Indexed keywords

ACICLOVIR; ALGINIC ACID; AMOXICILLIN; CAPTOPRIL; CARBOMER; CARBOXYMETHYLCELLULOSE; CHITOSAN; ECONAZOLE; FAMOTIDINE; FUROSEMIDE; GLIPIZIDE; GUM ARABIC; HUMAN GROWTH HORMONE; HYALURONIC ACID; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; METHYLPREDNISOLONE; METOPROLOL TARTRATE; PECTIN; PIOGLITAZONE; POLYACRYLIC ACID; POLYCARBOPHIL; POLYMER; POVIDONE; SALCATONIN; SUMATRIPTAN SUCCINATE; TRIPOLYPHOSPHATE; UNINDEXED DRUG;

AREA UNDER THE CURVE; CONTROLLED DRUG RELEASE; CROSS LINKING; DIFFUSION COEFFICIENT; DRUG ABSORPTION; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG HALF LIFE; DRUG SYNTHESIS; EVAPORATION; EX VIVO STUDY; GASTROINTESTINAL TRANSIT; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MICROCAPSULE; MICROENCAPSULATION; MIGRAINE; MUCOADHESION; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PATENT; PHYSICAL CHEMISTRY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SHEAR STRENGTH; SHELF LIFE; SPRAY DRYING;

ADHESIVENESS; ALGINATES; ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MICROSPHERES; MUCOUS MEMBRANE; PATENTS AS TOPIC; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 84867780148     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221112802652697     Document Type: Review

References (157)

1. Woodley J. Bioadhesion: New possibilities for drug administration? Clin Pharmacokinet 2001; 40: 77-84.
2. Tang ESK, Chan LW, heng PWS. Coating of muliparticulate for sustained release. Amer J Drug Delivery 2005; 3: 17-28.
3. Carvalho FC, Brushchi ML, Evangelista RC, Gremiao MPD. Mucoadhesive drug delivery systems. Braz J Pharm Sci 2010; 46: 1-17.
4. Hogerstrom H, Edsman K, Strwmme M. Low-frequency dielectric spectroscopy as a tool for studying the compatibility between pharmaceutical gels and mucus tissue. J Pharm Sci 2003; 92:1869-81.
5. Andrews GP, Thomas P, Laverty T P, David S, Jones S. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm 2009; 71: 505-18.
6. Peppas NA, Puri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissue. J Controlled Release 1985; 2: 257-75.
7. Mikos AG, Peppas NA. Measurement of the surface tension of mucin solutions. Int J Pharm 1989; 3: 1-5.
8. Lehr CM, Bodde HE, Bowstra JA, Junginger HE. A surface energy analysis of mucoadhesion. II: Prediction of mucoadhesive performance by spreading coefficients. Eur J Pharm Sci 1993; 1: 19-30.
9. Derjaguin BV, Toporov YP, Muller VM, Aleinkova IN. On the relationship between the molecular component of the adhesion of elastic particles to a solid surface. J Colloid Interface Sci 1966; 58: 528-33.
10. Kammer HW. Adhesion between polymers. Acta Polym 1983; 34: 112.
11. Good RJ. Surface energy of solids and liquids. Thermodynamics, molecular forces, and structure. J Colloid Interface Sci 1977; 59: 398-419.
12. Tabor D. Surface forces and surface interactions. J Colloid Interface Sci 1977; 58: 2-13.
13. Mikos AG, Peppas NA. Systems for controlled release of drugs. V. Bioadhesive systems. STP Pharmacol 1986; 2: 705-16.
14. Kirschner, M.I., St. Louis, M.O., Saullevinson, R., Chresterfield, M.O., Riky, T.C., Manchester, M.O., Marc, S.H., Louis, M.O. Bioadhesive drug delivery system. US0180366A1 (2003).
15. Harsulkar AA, Sreenivas SA, Mandade RJ, Wakada RB. Polymers in mucoadhesive drug delivery system-A review. Int J Drug Form Res 2011; 2(3): 61-7.
16. Rao YM, Jithan AV. Advances in drug delivery 2011; 1: 156-59.
17. Patil SB, Murthy RSR, Mahajan HS, Wagh RD, Gattani SG. Mucoadhesive polymers: Means of improving drug delivery. Pharma Times 2006; (38): 25-8.
18. Woodley J, Bioadhesion, new possibilities for drug administration? Clin Pharmacokinet 2001; 40(2): 77-84.
19. Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly (isobutiyl cyanoacrylate) core-shell nanoparticles. Biomaterials 2007; 28(13): 2233-43.
20. Wittaya-areekul S, Kruenate J, Prahsarn C. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int J Pharm 2006; 312(1-2): 113-18.
21. Mortazavi SA, Moghimi HR. Effect of surfactant type and concentration on the duration of mucoadhesion of carbopol 934 and hpmc solid compacts. Ir J Pharm Res 2003; 2(4): 191-99.
22. Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: The next generation. J Pharm Sci 2000; 89(7): 850-66.
23. Chowdary CPR, Rao YS. Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull 2004; 27(11): 1717-24.
24. Lehr CM. Lectin-mediated drug delivery: The second generation of bioadhesives. J Controlled Release 2000; 65(1): 19-29.
25. Kopecek J, Kopeckova P, Minko T, Lu Z. HPMA copolymeranticancer drug conjugates: Design, activity, and mechanism of action. Eur J Pharm Biopharm 2000; 50(1): 61-81.
26. Orienti I, Aiedeh K, Gianasi E, Ponti C, Zecchi V. Chitosan indomethacin conjugates: Effect of different substituents on the polysaccharide molecule on drug release. Arch Pharm (Weinheim) 1996; 329: 245-50.
27. Thanoo BC, Sunny MC, Jayakrishnan A. Cross-linked chitosan microspheres: Preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J Pharm Pharmacol 1992; 44: 283-86.
28. Bodmeier R, Paeratakul O. Spherical agglomerates of waterinsoluble drugs. J Pharm Sci 1989; 78: 964-67.
29. Shiraishi S, Imai T, Otagiri M. Controlled release of indomethacin by chitosan polyelectrolyte complex: optimization and in vivo/ in vitro evaluation. J Controlled Release 1993; 25: 217-25.
30. Singla AK, Dhawan S. Nifedipine loaded chitosan microspheres prepared by emulsification phase separation. Biotech Histochem 2003; 78: 243-54.
31. Parmar H, Bakiwal S, Gujarathi N, Rane B, Pawar S. Different methods of formulation and evaluation of mucoadhesive microsphere. Int J Appl Biol Pharmaceutic Technol 2010; 1(1): 1157-67.
32. Lim ST, Martin GP, Berry DJ, Brown MB. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Controlled Release 2000; 66 (2-3): 281-92.
33. MI FL, Shyu SS, Kuan CY, Lee ST, Lu KT, Jang SF. Chitosan-Polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug: I: Effect of phosphorous polyelectrolyte complex and enzymatic hydrolysis of polymer. J Appl Polym Sci 1999; 74:1868-79.
34. Nishioka Y, Kyotani S, Okamura M, Miyazaki M, Okazaki K, Ohnishi SY, Yamamoto Y, Ito K. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. Chem Pharm Bull (Tokyo). 1990, 38, 2871-73.
35. Ohya Y, Takei T, Kobayashi H, Ouchi T. Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. J Microencapsul 1993; 10(1): 1-9.
36. Mathiowitz E, Langer R. Polyanhydride micro spheres as drug carriers-I, Hot melt microencapsulation. J Controlled Release 1987; 5: 13-22.
37. Mathiowitz, E., Chickering, D.E., Jacob, J.S. Bioadhesive microsphere and their use as drug delivery and imaging systems. US6235313B1 (2001).
38. Schnurch AB, Kast CE, Richter MF. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Controlled Release 2001; 71: 277-85.
39. Moodley. J., Coulter, Ivan. Dihydropyrimidine formulations. US20070292523 (2007).
40. Leonard M, Boisseson MR De, Hubert P, Dalencon F, Dellacherie E. Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties. J Controlled Release 2004; 98: 395-405.
41. Marón LB, Peniche C, Monal WA, Study of the interpolyelectrolyte reaction between chitosan and alginate: Influence of alginate composition and chitosan molecular weight. Int J Biol Macromol 2004; 34: 127-33.
42. Nordin, O., Ström, H., Nyholm, C., Hammer, C. Microspheres. US20110203756 (2011).
43. Gaserod O, Smidsrod O, Skjak-Braek G, Microcapsules of alginate-chitosan: I. A quantitative study of the interaction between alginate and chitosan. Biomaterials 1998; 19: 1815-25.
44. Chen JL, Chu IM, Shiao MY, Hsu BR, Fu SH, Microencapsulation of islets in PEG-amine modified alginate-poly-(lysine)-alginate microcapsules for constructing bioartificial pancreas. J Ferment Bioeng 1998; 86: 185-90.
45. Thu B, Bruheim P, Espevik T, Smidsrod O, Soon-Shiong P, Skjak-Braek G. Alginate polycation microcapsules: I. Interaction between alginate and polycation. Biomaterials 1996; 17: 1031-40.
46. Wang T, Lacik I, Brissova M, Prokop A, Hunkeler D, Anilkumar AV, et al. An encapsulation system for immunoisolation of pancreatic islets. Nat Biotechnol 1997; 15(4): 358-62.
47. Huguet ML, Neufeld RJ, Dellacherie E. Calcium-alginate beads coated with polycationic polymers: comparison of chitosan and DEAE-dextran. Process Biochem 1996; 31: 347-53.
48. Simhambhatla, M.V., Ding, N., Pacetti, S.D. Polycationic peptide coatings and methods of making the same. US7011842 (2006).
49. Almeida PF, Almeida AJ. Cross-linked alginate-gelatine beads: A new matrix for controlled release of pindolol. J Controlled Release 2004; 97: 431-39.
50. Mohammed G Ahmed, Satish KBP, Kiran KGB. Formulation and evaluation of gastric-mucoadhesive drug delivery systems of captopril. J Current Pharm Res 2010; 2(1): 26-32.
51. Arya RKK, Singh R, Juyal V. Mucoadhesive microspheres of famotidine: Preparation characterization and in vitro evaluation. Int J Eng Sci Tech 2010; 2(6): 1575-80.
52. Krishna RR, Murthy TEGK. Preparation and evaluation of mucoadhesive microcapsules of glipizide formulated with gum kondagogu: In vitro and in vivo. Acta Pharmaceutica Sciencia 2010; 52: 335-44.
53. Belgamwar V, Shah V, Surana SJ. Formulation and evaluation of oral mucoadhesive multiparticulate system containing metoprolol tartarate: An in vitro-ex vivo characterization. Curr Drug Deliv 2009; 6: 113-21.
54. Kalyankar TM, Rangari NT, Khan M, Hosmani A, Sonwane A. Formulation and Evaluation of Mucoadhesive Pioglitazone HCl Microspheres. Int J Pharm World Res 2010; 1(3):1-14.
55. Tao Y, Lu Y, Sun Y, Gu B, Lu W, Pan J. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability. Int J Pharm 2009; 378: 30-6.
56. Reddy KK, Narasimharao R, Jagadeeshbabu V, Chandrasheker RA. Formulation and evaluation of Metformin HCl microspheres. Int J Pharm Tech 2011; 3: 2228-47.
57. Odonnell P, McGinity J. Preparation of Microspheres by the solvent evaporation technique. Adv Drug Del Rev 1997; 28: 25-42.
58. Biswal I, Dinda A, Das D, SI S, Chowdary KA. Encapsulation protocol for highly hydrophilic drug using nonbiodegradable polymer. Int J Pharm Pharm Sci 2011; 3(2): 257-59.
59. Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004; 282: 1-18.
60. Das MK, Rama Rao K. Evaluation of zidovudine encapsulated ethylcellulose microspheres prepared by water-in-oil-in-oil (w/o/o) double emulsion solvent diffusion technique. Acta Polo Pharm Drug Res 2006; 63 (2): 141-8.
61. Ponchel G, Touchard F, Duchene D, Peppas NA. Bioadhesive analysis of controlled release systems. I. Fracture and interpenetration analysis in poly (acrylic acid)-containing systems. J Controlled Release 1987; 5:129-41.
62. Ahuja A, Khar R, Ali J. Mucoadhesive drug delivery systems. Drug Dev Ind Pharm 1997; 23: 489-515.
63. Chen JL, Cyr GN. Compositions producing adhesion through hydration. In: Marly RS, ed. adhesion in biological systems. New York: Academic, 1970: 163-81.
64. Needleman IG, Smales FC. In vitro assessment of bioadhesion for periodontal and buccal drug delivery. Biomaterials 1995; 16: 617-24.
65. Park K, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery: Method to study bioadhesion. Int J Pharm 1984; 19:107.
66. Ranga RKV, Buri P. A novel in situ method to test polymers and coated microparticles for bioadhesion. Int J Pharm 1989; 52: 265-70.
67. Nantwi PKK, Cook DJ, Rogers DJ, Smart JD. Lectins for drug delivery within the oral cavity-investigation of lectin binding to oral mucosa. J Drug Target 1997; 5: 45-5.
68. Mikos AG, Peppas NA. Scaling concepts and molecular theories of adhesion of synthetic polymers to glycoproteinic networks. In: Lenaerts V, Gurny R, eds. Bioadhesive drug delivery systems. Boca Raton, FL: CRC, 1990: 25-42.
69. Teng CLC, Ho NFH. Mechanistic studies in the simultaneous flow and adsorption of polymer-coated latex particles on intestinal mucus I: Methods and physical model development. J Controlled Release 1987; 6:133-49.
70. Park K. A new approach to study mucoadhesion: Colloidal gold staining. Int J Pharm 1989; 53: 209-17.
71. Kamath KR, Park K. Mucosal adhesive preparation. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker 1994; 10: 133-63.
72. Hassan EE, Gallo JM. A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res 1990; 7: 491-95.
73. Mathiowitz E, Chickering D, Jacob JS, Santos C. Bioadhesive drug delivery systems. In: Mathiowitz E (Eds.), Encyclopedia of Controlled Drug Delivery. Wiley, New York 1999; 1: 9-44.
74. Richardson JL, Whetstone J, Fisher NF, Watts P, Farraj NF, Hinchcliffe M, et al. Gamma scintigraphy as a novel method to study the distribution and retention of a bioadhesive vaginal delivery system in sheep. J Controlled Release 1999; 42:133-42.
75. Biacore 3000 Instrument Handbook BR-1003-81 Edition AG, 1-14.
76. Park K, Robinson JR. Bioadhesive polymers as platforms for oralcontrolled drug delivery:Mehod to study bioadhesion, Int J Pharm 1984;19:107-27.
77. Pilgaonkar, P.S., Rustomjee, M.T., Gandhi, A., Kumar, S., Suvarnapathaki, R.K. Compositions exhibiting delayed transit through the gastrointestinal tract. US20110229569 (2011).
78. Patel VM, Prajapati BG, Patel MM, Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS Pharm Sci Tech 2007; 8: 22.
79. Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G. Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery. J Controlled Release 2005; 102: 159-69.
80. Scott, T.L., Brown, L.R., Riske, F.J., Blizzard, C.D., Rashba-step, J. Sustained release microspheres. US6458387 (2002).
81. Jones D, Woolfson AD, Brown A, Coulter W, McClelland C, Irwin C. Design, characterisation and preliminary clinical evaluation of a novel Mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Controlled Release 2000; 67: 357-68.
82. Junginger H, Hoogstraate J, Verhoef JC. Recent advances in buccal drug delivery and absorption-in vitro and in vivo studies. J Controlled Release 1999; 62: 149-59.
83. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: Swelling, mechanical, and bioadhesive properties. J Pharm Sci 1999; 2: 53-61.
84. Hoogstraate JJ, Wertz P, Wertz P. Drug delivery via the buccal mucosa. Pharm Sci Technol 1998; 1: 309-16.
85. Saettone M, Salminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev1995; 16: 95-6.
86. Carlfors J, Edsman K, Petersson R, Jornving K. Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 1998; 6: 113-9.
87. Grzekowiak E. Biopharmaceutical availability of sulphadicramide from ocular ointments in vitro. Eur J Pharm Sci 1998; 6: 247-53.
88. Wei G, Xu H, Ding P, Li S, Zheng J. Thermosetting gels with modulated gelation temperature for ophthalmic use: The rheological and gamma scintigraphic studies. J Controlled Release 2002; 83: 65-74.
89. Jungherr, L.B., Ottoboni, T.B. Ocular microsphere delivery system. US5837226 (1998).
90. Amaral E, Perdigao A, Souza M, Mauck C, Waller D, Zaneveld L, Faundes A. Vaginal safety after use of a bioadhesive, acidbuffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product. Contraception 2006; 76: 542-47.
91. Scott, T., Lafreniere, D., Bisker-leib, V., Brown, L. Nucleic acid microspheres, production and delivery thereof. US20110033551 (2011).
92. Djupesland, P.G., Hafner, R.P. Nasal delivery. US20090304802 (2009).
93. Soane RJ, Frier M, Perkins AC, Jones NS, Davis SS, Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm 1999; 178: 55-65.
94. Pisal S, Paradkar A, Mahadik K, Kadam S. Pluronic gels for nasal delivery of Vitamin B12. Part I: Preformulation study. Int J Pharm 2004; 270: 37-45.
95. Unger, E.C. Composition comprising low density microspheres. US7344705 (2008).
96. Hagan DTO, Rafferty D, Wharton S, Illum L. Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system. Vaccine 1993; 11: 660-64.
97. Modi, P. Vaccine delivery system for immunization, using biodegradable polymer microspheres. US 5569468 (1996).
98. Payne, L.G., Woods, A.L., Jenkins, S.A. Polyphosphazene microspheres. US6207171B1 (2001).
99. Bernkop SAS, Dundalek K. Novel bioadesive drug delivery system protecting (poly) peptides from gastric enzymatic degradation. Int J Pharm 1996; 138: 75-83.
100. Day, R.M., Blaker, J. Microspheres. US20100247663 (2010).
101. Borchard G, Luessen HL, deBoer AG, Verhoef JC, Lehr CM, Junginger HE. The potential of Mucoadhesive polymers in enhancing intestinal peptide drug absorption. III. Effects of chitosanglutamate and carbomer on epithelial tight junctions in vitro. J Controlled Release 1996; 39: 131-38.
102. Luessen HL, Verhoef JC, Borchard G, Lehr CM, deBoer AG, Junginger HE. Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm Res 1995; 12: 1293-8.
103. Ishida M, Machida Y, Nambu N, Nagai T. New mucosal dosage form of insulin. Chem Pharm Bull 1981; 29: 810-16.
104. Marvola M, Vahervou K, Rajaneimi M. Development of a method for studying the tendency of drug products to adhere to the esophagus. Pharm Sci 1982; 71: 975-7.
105. Marvola M, Rajaneimi M, Marttila E, Vahervuo K, Sothmann A. Effect of dosage form and formulation factors on the adherence of drugs to the esophagus. J Pharm Sci 1983; 72: 1034-6.
106. Ch'ng HS, Park H, Kelly P, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling, water insoluble bioadhesive polymers. J Pharm Sci 1985; 74: 399-405.
107. Park H, Robinson JR. Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion. J Controlled Release 1985; 2: 47-57.
108. Park H, Robinson JR. Mechanisms of mucoadhesion of poly (acrylic acid) hydrogels. Pharm Res 1987; 4: 457-64.
109. Ponchel G, Touchard F, Wouessidjewe D, Duchene D, Peppas NA. Bioadhesive analysis of controlled-release systems. III. Bioadhesive and release behavior of metronidazole-containing poly (acrylic acid)-hydroxypropyl methylcellulose systems. Int J Pharm 1987; 38: 65-70.
110. Lejoyeux F, Ponchel G, Wouessidjewe D, Peppas NA, Duchene D. Bioadhesive tablets influence of the testing medium composition on bioadhesion. Drug Dev Ind Pharm 1989; 15: 2037-48.
111. Smart JD. An in vitro assessment of some mucosa-adhesive dosage forms. Int J Pharm 1991; 73(1): 69-74.
112. Satoh K, Takayama K, Machida Y, Suzuki Y, Nakagaki M, Nagai T. Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer. Chem Pharm Bull 1989; 37: 1366-68.
113. Bottenberg P, Cleymaet R, de Muynck C, Remon JP, Coomans D, Michotte Y, Slop D. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol 1991; 43: 457-64.
114. Lehr CM, Bouwstra JA, Tukker JJ, Junginger HE. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat-A comparative study with copolymers and blends based on poly (acrylic acid). J Controlled Release 1990; 13: 51-62.
115. Saettone MF, Chetoni P, Torracca MT, Burgalassi S, Giannaccini B. Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int J Pharm 1989; 51: 203-12.
116. Chen WG, Hwang GCC. Adhesive and in vitro release characteristics of propranolol bioadhesive disc system. Int J Pharm 1992; 82: 61-6.
117. Chickering D, Jacob J, Panol G, Mathiowitz E. A tensile technique to evaluate the interaction of bioadhesive microspheres with intestinal mucosa. Proc Int Symp Control Rel Bioact Mater 1992; 19: 88-9.
118. Thermes F, Grove J, Rozier A, Plazonnet B, Constancis A, Bunel C, Vairon JP. Mucoadhesion of copolymers and mixtures containing polyacrylic acid. Pharm Res 1992; 9: 1563-7.
119. Bouckaert S, Remon J. In vitro bioadhesion of a buccal, miconazole slowrelease tablet. J Pharm Pharmacol 1993; 45: 504-7.
120. Jimenez-Castellanos MR, Zia H, Rhodes CT. Assessment of an in vitro method for measuring the bioadhesiveness of tablets. Int J Pharm 1993; 89: 223-8.
121. Jian-hwa G. Investigating the surface properties and bioadhesion of buccal patches. J Pharm Pharmacol 1994; 46(8): 647-50.
122. Jian-Hwa G. Bioadhesive polymer buccal patches for buprenorphine controlled delivery: Formulation, In vitro adhesion and release properties. Drug Dev Ind Pharm 1994; 20(18): 2809-21.
123. Save T, Shah UM, Ghamande AR, Venkitachalam P. Comparative study of buccal adhesive formulations and sublingual capsules of nifedipine. J Pharm Pharmacol 1994; 46: 192-95.
124. Miyazaki S, Nakayama A, Oda M, Takada M, Attwood D. Chitosan and sodium alginate based bioadhesive tablets for intraoral delivery. Bio Pharm Bull 1994; 17: 745-7.
125. Martini L, Attwood D, Collect JH, D'Emanucle A. The bioadhesive properties of a triblock copolymer of ε-caprolactone and ethylene oxide. Int J Pharm 1995; 113: 223-9.
126. Rillosi M, Buckton G. Modeling mucoadhesion by use of surface energy terms obtained by the Lewis acid-Lewis base approach. Int J Pharm 1995; 117: 75-84.
127. Smart JD, Lellaway IW, Worthington HEC. An in vitro investigation of mucosaadhesive materials for use in controlled drug delivery. J Pharm Pharmacol 1984; 36: 295-9.
128. Ishida M, Nambu M, Nagai T. Ointment-type oral mucosal dosage form of Carbopol containing prednisolone for treatment of aphtha. Chem Pharm Bull 1983; 31:1010-14.
129. Gurny R, Meyer JM, Peppas NA. Bioadhesive intraoral release systems: Design, testing and analysis. Biomaterials 1984; 5: 336-40.
130. Sham AP, Van den Heuij JTM, Tukker JJ. Mucoadhesion of both film-forming and non-film-forming polymeric materials as evaluated with the Wilhelmy plate method. Int J Pharm 1992; 79: 97-105.
131. Genta I, Conti B, Perugini P, Pavanetto F, Spadaro A, Puglisi G. Bioadhesive microspheres for ophthalmic administration of Acyclovir. J Pharm Pharmacol 1997; 49: 737-42.
132. Yellanki SK, Singh J, Syed JA, Bigala R, Goranti S, Nerella NK. Design and characterization of amoxicillin trihydrate mucoadhesive microspheres for prolonged gastric retention. Int J Pharm Sci Drug Res 2010; 2(2): 112-4.
133. Kyyronen K, Hume L, Benedetti L, Urtti A, Topp E, Stella V. Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: In vitro and in vivo release studies. Int J Pharm 1992; 80: 161-9.
134. Farraj NF, Johansen BR, Davis SS, Illum L. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J Controlled Release 1990; 13; 253-61.
135. Illum L, Farraj NF, Davis SS, Johansen BR, O'Hagan DT. Investigation of the nasal absorption of biosynthetic human growth hormone in sheep-use of a bioadhesive microsphere delivery system. Int J Pharm 1990; 63: 207-11.
136. Albertini B, Passerini N, Sabatino MD, Vitali B, Brigidi P, Rodriguez L. Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci 2009; 36: 591-601.
137. Akiyama Y, Nagahara N. Novel formulation approaches to oral mucoadhesive drug delivery systems. In: Mathiowitz E, Chickering DE, Lehr CM. (Eds.), Bioadhesive drug delivery systemsfundamentals, novel approaches and development '98. Marcel Dekker, New York, 1999; 477-505.
138. Akiyama Y, Yoshioka M, Horibe H, Inada Y, Hirai S, Kitamori N, Toguchi H. Anti-hypertensive effect of oral controlled release microspheres containing an ACE inhibitor (Delapril hydrochloride) in rats. J Pharm Pharmacol 1994; 46: 661-5.
139. Martinac A, Filipovic-Grcic J, Voinovich D, Perissutti B, Franceschinis E. Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery. Int J Pharm 2009; 291: 69-77.
140. Geary S, Schlameus HW. Vancomycin and insulin used as models for oral delivery of peptides. J Controlled Release 1993; 23: 65-74.
141. Patel J, Patel D, J Raval. Formulation and evaluation of propranolol hydrochloride-loaded carbopol-934p/ethyl cellulose mucoadhesive microspheres. Iran J Pharm Res 2010; 9(3): 221-32.
142. Miyazaki Y, Ogihara K, Yakou S, Nagai T, Takayama K. In vitro and in vivo evaluation of mucoadhesive microspheres consisting of dextran derivatives and cellulose acetate butyrate. Int J Pharm 2003; 258: 21-9.
143. Jules, S.J., Peyman, M., Avinash, N., Ze'ev, S., Mark, K. Mucoadhesive oral formulations of high permeability, high solubility. US0281007A1 (2007).
144. Giancarlo, S., Giuseppe, B., Caterina, L. Controlled release mucoadhesive pharmaceutical composition for the oral administration of Furosemide. US5571533 (1996).
145. Edith, M., Donald, C., Jules, S.J. Bioadhesive microspheres and their use as drug delivery and imaging systems. US6235313B1 (2001).
146. Adi, S., Shamuel, D.S. Biodegradable bioadhesive controlled release system of nanoparticle for oral care products. US6565873B1 (2003).
147. Adi, S., Shamuel, D.S. Multicomponent biodegradable bioadhesive controlled release system for oral care products. US6589562B1(2003).
148. Gregory E.H., Lloyd, G., Tillman, M.G.F., Rahul, C., Mehta, C.L.T. Multiparticulate formulation. US0027780A1 (2003).
149. Rosario, L., Hans-Ulrich, P., Erna, R., Ines, A., Michael, D. Multiparticulate pharmaceutical dosages form containing a mucoadhesively formulated peptide or protein actives substances method for producing said pharmaceuitical dosages form. US0026082A1 (2007).
150. Allan, E., David, R.Z., Yoon, J.P., Arthur, Z.Y., Victor, C.Y. Mucoadhesive nanocomposite delivery system. US0232899A1 (2009).
151. Rosario, L., Hans-Ulrich, P., Dave, T., Michael, G. Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients and method for producing said form of administration. US0280183A1 (2009).
152. Jacob, J., Nangia, A., Yeh, J., Ramanan, V. Bioadhesive polymers. US 0086095A1 (2011).
153. Dash, A.K., Trickler W.J. Mucoadhesive nanoparticles for Cancer treatment. US0323977A9 (2010)
154. Nangia, A., Jacob, J., Moslemy, P. Bioadhesive rate controlled oral dosages formulations. US0260824A1 (2008)
155. Rao, S.V.R., Shah, S.M., Tatapudy, H., Saunders, W., Fawzi, M., Nagi, A. et al. Pantoprazole Multiparticulate formulations. US0196443A1 (2007)
156. Fernandez, A.A., Garcia A.C., Martin, R.M.H., Olaechea, M.I., Munoz, J.L.P., Gascon, A.R. Semisolid mcoadhesive formulations. US0240111A1 (2006)
157. Masters, D.B., Berg E.P. Drug delivery devices and methods of making and using thereof. US0196440 A1 (2005)